A genetic contribution to bone mass determination was first described in the early 70s. Elucidation of gene contribution to this has since been attempted through studies analyzing associations between bone mass acquisition and/or maintenance and polymorphic variations of several genes. The first to be described was the vitamin D receptor gene (VDR), initially claimed to contribute to almost 75% of the genetic variation in bone mineral density (BMD) in twin and general population studies. Not all of the studies published to date conclude that a clear relationship exists between polymorphic VDR alleles and BMD, and the molecular basis for the VDR gene polymorphisms influence on bone mineralization has not yet been clarified. Since then, other genes with a significant role in bone metabolism such as estradiol receptor, collagen type 1α1, TGF-β1, interleukin-6, calcitonin receptor, α2-HS-glycoprotein, osteocalcin, calcium-sensing receptor, interleukin-1 receptor antagonist, β3-adrenergic receptor, apolipoprotein E, PTH, IGF-I and glucocorticoid receptor have been analyzed. Some polymorphic variations in these genes have been associated in some works with significant differences in BMD, with even more significant contributions when associations of different gene polymorphisms were analyzed. Again, the molecular basis for the contribution of these alleles to bone mass determination has not yet been described. A different approach has been attempted by linkage analysis of loci involved in bone density in pedigrees with low BMD using BMD as a quantitative trait. Recent results do not confirm, in these families, any association with any of the previously reported genes, but rather with other as yet unidentified genes. The genetic contribution to mild variations in the general population, as a result of environmental and endogenous individual influences, probably differs completely from that providing a pathologic BMD.

Keywords:
Bone mass, VDR gene polymorphism, Genetic determinants
1.
Cummings SR, Kelsey JL, Nevitt MC, O’Dowd KJ: Epidemiology of osteoporosis and osteoporotic fracture. Epidemiol Rev 1985;7:178–208.
2.
Spencer H, Kramer L: NIH consensus conference: Osteoporosis. Factors contributing to osteoporosis. J Nutr 1986;116:319–322.
3.
De Río L, Carrascosa A, Pons F, Gussinyé M, Yeste D, Domenech M: Bone mineral density of the lumbar spine in white Mediterranean Spanish children and adolescents: Changes related to age, sex and puberty. Pediatr Res 1994;35:362–366.
4.
Carrascosa A, Gussinyé M, Yeste D, del Río L, Audí L: Bone mass acquisition during infancy, childhood and adolescence. Acta Paediatr 1995(suppl 44):18–23.
5.
Carrascosa A, Silber ThJ: Osteoporosis: A pediatric concern? Int Pediatr 1996;11:84–94.
6.
Carrascosa A, Gussinyé M, Yeste D, del Río L, Audí L, Enrubia M, Vargas D: Skeletal mineralization during infancy, childhood and adolescence in the normal population and in populations with nutritional and hormonal disorders. Dual X-ray absorptiometry (DEXA) evaluation; in Schönau E (ed): Paediatric Osteology: New Developments in Diagnostics and Therapy. Amsterdam, Elsevier Science, 1996, pp 93–102.
7.
Smith DM, Nance WE, Kang KW, Christian JC, Johnston CC Jr: Genetic factors in determining bone mass. J Clin Invest 1973;52:2800–2808.
8.
Pocock NA, Eisman JA, Hopper JL, Yeates MG, Sambrook PN, Eberl S: Genetic determinants of bone mass in adults. A twin study. J Clin Invest 1987;80:706–710.
9.
Dequecker J, Nijs J, Verstraeten A, Geusens P, Gevers G: Genetic determinants of bone mineral content at the spine and radius: A twin study. Bone 1987;8:207–209.
10.
Seeman E, Hopper JL, Bach LA, Cooper ME, Parkinson E, McKay J, Jerums G: Reduced bone mass in daughters of women with osteoporosis. N Engl J Med 1989;320:554–558.
11.
Krall EA, Dawson-Hughes B: Heritable and life-style determinants of bone mineral density. J Bone Miner Res 1989;4:1–9.
12.
Kelly PJ, Hopper JL, Macaskill GT, Pocock NA, Sambrook PN, Eisman JA: Genetic factors in bone turnover. J Clin Endocrinol Metab 1991;72:808–813.
13.
Slemenda CW, Christian JC, Williams CJ, Norton JA, Johnston CC Jr: Genetic determinants of bone mass in adult women: A reevaluation of the twin model and potential importance of gene interaction on heritability estimates. J Bone Miner Res 1991;6:561–567.
14.
Hansen MA, Hassager C, Jensen SB, Christiansen C: Is heritability a risk factor for postmenopausal osteoporosis? J Bone Miner Res 1992;7:1037–1043.
15.
Soroko SB, Barret-Conner E, Edelstein SL, Kritz-Silverstein D: Family history of osteoporosis and bone mineral density at the axial skeleton: The Rancho Bernardo study. J Bone Miner Res 1994;9:761–769.
16.
Hopper JL, Green RM, Nowson CA, Young D, Sherwin AJ, Kaymakci B, Larkins RG, Wark JD: Genetic, common environment, and individual specific components of variance for bone mineral density in 10- to 25-year-old females: A twin study. Am J Epidemiol 1988;147:17–29.
17.
Livshits G, Karasik D, Otremski I, Kobyliansky E: Genes play an important role in bone aging. Am J Hum Biol 1998;10:421–438.
18.
Eisman JA: Genetics of osteoporosis; in Papapoulos SE, Lips P, Johnston CC, Delmas PD (eds): Osteoporosis 1996. Amsterdam, Elsevier Science, 1996, pp 131–135.
19.
Rogers J, Mahaney MC, Beamer WG, Donahue LR, Rosen CJ: Beyond one gene-one disease: Alternative strategies for deciphering genetic determinants of osteoporosis. Calcif Tissue Res 1997;60:225–228.
20.
Keen RW, Kelly PJ: Genetic factors in osteoporosis. What are the implications for prevention and treatment? Drugs Aging 1997;11:333–337.
21.
Parfitt AM: Genetic effects on bone mass and turnover – Relevance to black/white differences. J Am Coll Nutr 1997;16:325–333.
22.
Greenfield EM, Goldberg VM: Genetic determination of bone density. Lancet 1997;350:1263.
23.
Nguyen TV, Howard GM, Kelly PJ, Eisman JA: Bone mass, lean mass, and fat mass: Same genes or same environments? Am J Epidemiol 1998;147:3–16.
24.
Gilsanz V: Phenotype and genotype of osteoporosis. TEM 1998;9:184–190.
25.
Wood RJ, Fleet JC: The genetics of osteoporosis. Vitamin D receptor polymorphisms. Annu Rev Nutr 1998;18:233–258.
26.
Bouillon R, Okamura WH, Norman AW: Structure-function relationships in the vitamin D endocrine system. Endocr Rev 1995:16:200–257.
27.
Haussler MR, Whitfield GK, Haussler CA, Hsieh JC, Thompson PD, Selznick SH, Encinas Dominguez C, Jurutka PW: The nuclear vitamin D receptor: Biological and molecular regulatory properties revealed. J Bone Miner Res 1998;13:325–349.
28.
McDermott MF, Ramachandran A, Ogunkolade BW, Aganna E, Curtis D, Boucher BJ, Snehalatha C, Hitman GA: Allelic variation in the vitamin D receptor influences susceptibility to IDDM in Indian Asians. Diabetologia 1997;40:971–975.
29.
Hitman GA, Mannan M, McDermott MF, Aganna E, Ogunkolade BW, Hales CN, Boucher BJ: Vitamin D receptor gene polymorphism influence insulin secretion in Bangladeshi Asians. Diabetes 1998;47:688–690.
30.
Uitterlinden AG, Burger H, Huang Q, van Duijn CM, Hofman A, Birkenhäger JC, van Leeuwen JPTM, Pols HAP: Vitamin D receptor genotype is associated with osteoarthritis; in Papapoulos SE, Lips P, Johnston CC, Delmas PD (eds): Osteoporosis 1996. Amsterdam, Elsevier Science, 1996, pp 395–399.
31.
Uitterlinden AG, Burger H, Huang Q, Odding E, van Duijn CM, Hofman A, Birkenhäger JC, van Leeuwen JPTM, Pols HAP: Vitamin D receptor genotype is associated with radiographic osteoarthritis at the knee. J Clin Invest 1997;100:250–263.
32.
Keen RW, Hart DJ, Lanchbury JS, Spector TD: Association of early osteoarthritis of the knee with a TaqI polymorphism of the vitamin D receptor gene. Arthritis Rheum 1997;40:1444–1449.
33.
Labuda M, Fujiwara TM, Ross MV, Morgan K, Garcia-Heras J, Ledbetter DH, Hughes MR, Glorieux FH: Two hereditary defects related to vitamin D metabolism map to the same region of human chromosome 12q13-14. J Bone Miner Res 1992;12:1447–1453.
34.
Pike JW, McDonnell DP, Scott RA, Kerner SA, Kesterson RA, O’Malley B: The vitamin D3 receptor and its chromosomal gene; in Gustafson JA (ed): The Steroid/Thyroid Hormone Receptor Family and Gene Regulation. Basel, Birkhäuser, 1989, pp 147–159.
35.
Morrison NA, Yeoman R, Kelly PJ, Eisman JA: Contribution of trans-acting factor alleles to normal physiological variability: Vitamin D receptor gene polymorphisms and circulating osteocalcin. Proc Natl Acad Sci USA 1992;89:6665–6669.
36.
Morrison NA, Qi JC, Tokita A, Kelly PJ, Crofts L, Nguyen TV, Sambrook PN, Eisman JA: Prediction of bone density from vitamin D alleles. Nature 1994;367:284–287.
37.
Spector TD, Keen RW, Arden NK, Major PJ, Baker JR, Morrison NA, Kelly PJ, Sambrook PN, Lanchbury JS, Eisman JA: Vitamin D receptor gene alleles and bone density in postmenopausal women: A UK twin study. J Bone Miner Res 1994;9:S143.
38.
Yamagata Z, Miyamura T, Iijima S, Asaka A, Sasaki M, Kato J, Koizumi K: Vitamin D receptor gene polymorphism and bone mineral density in healthy Japanese women. Lancet 1994:344:1027.
39.
Melhus H, Kindmark A, Amér S, Wilén B, Lindh E, Ljunghall S: Vitamin D receptor genotypes in osteoporosis. Lancet 1994;344:949–950.
40.
Hustmyer FG, Peacock M, Hui S, Johnston CC, Christian J: Bone mineral density in relation to polymorphism at the vitamin D receptor gene locus. J Clin Invest 1994;94:2130–2134.
41.
Gallagher JC, Goldgar D, Kinyamu H, Fannon P: Vitamin D receptor genotypes in type I osteoporosis. J Bone Miner Res 1994;9:S143.
42.
Looney J, Fisher M, Yoon H, Wergedal J, Farley S, Sparkes R, Baylink D: Lack of evidence for an increased prevalence of the BB vitamin D receptor genotype in severe osteoporosis. J Bone Miner Res 1994;9:S148.
43.
Parfitt AM: Vitamin D receptor genotypes in osteoporosis. Lancet 1994;344:1580.
44.
Farrow A: Allelic variation and vitamin D receptor. Lancet 1994;343:1242.
45.
Kröger H, Mahonen A, Ryhänen S, Turunen AM, Alhava E, Mäenpää P: Vitamin D receptor genotypes and bone mineral density. Lancet 1995;345:1238.
46.
Keen RW, Major PJ, Lanchbury JS, Spector TD: Vitamin-D-receptor-gene polymorphism and bone loss. Lancet 1995;345:990.
47.
Lim SK, Park YS, Park JM, Song YD, Lee EJ, Kim KR, Lee HC, Huh KB: BB genotype of VDR is not a good marker for prediction of low bone density. 77th Annual Meeting. The Endocrine Society, Washington 1995, abstr P2-598.
48.
Ferrari S, Rizzoli R, Chevalley T, Slosman D, Eisman JA, Bonjour JP: Vitamin-D-receptor-gene polymorphisms and changes in lumbar-spine bone mineral density. Lancet 1995;345:423–424.
49.
Ferrari SL, Rizzoli R, Chevalley T, Eisman J, Bonjour JP: Vitamin D receptor genotypes and bone mineral density. Lancet 1995;345:1239.
50.
Barger-Lux MJ, Heaney RP, Hayes J, DeLuca HF, Johnson ML, Gong G: Vitamin D receptor gene polymorphism, bone mass, body size, and vitamin D receptor density. Calcif Tissue Int 1995;57:161–162.
51.
Ingles SA, Haile RW, Henderson BE, Kolonel LN, Nakaichi G, Shi CY, Yu MC, Ross RK, Coetzee GA: Strength of linkage disequilibrium between two vitamin D receptor markers in five ethnic groups: Implications for association studies. Cancer Epidemiol Biomarkers Prev 1997;6:93–98.
52.
Ingles SA, Ross RK, Yu MC, Irvien RA, La Pera G, Haile RW, Coetzee GA: Association of prostate cancer risk with genetic polymorphisms in vitamin D receptor and androgen receptor. J Natl Cancer Inst 1997;89:166–170.
53.
Arai H, Miyamoto KI, Taketani Y, Yamamoto H, Iemori Y, Morita K, Toani T, Nishisho T, Mori S, Takeda E: A vitamin D receptor gene polymorphism in the translation initiation codon: Effect on protein activity and relation to bone mineral density in Japanese women. J Bone Miner Res 1997;12:915–921.
54.
Gross C, Eccleshall TR, Malloy OJ, Villa ML, Marcus R, Feldman D: The presence of a polymorphism at the translation initiation site of the vitamin D receptor gene is associated with low bone mineral density in postmenopausal Mexican-American women. J Bone Miner Res 1996;11:1850–1855.
55.
Harris SS, Eccleshall TR, Gross C, Dawson-Hughes B, Feldman D: The vitamin D start codon polymorphism (FokI) and bone mineral density in premenopausal American black and white women. J Bone Miner Res 1997;12:1043–1048.
56.
Garnero P, Borel O, Sornay-Rendu E, Delmas PD: Vitamin D receptor gene polymorphisms do not predict bone turnover and bone mass in healthy premenopausal women. J Bone Miner Res 1995;10:1283–1288.
57.
Eccleshall TR, Garnero P, Gross C, Delmas PD, Feldman D: Lack of correlation between start codon polymorphism of the vitamin D gene and bone mineral density in premenopausal French women: The Ofely study. J Bone Miner Res 1998;13:31–35.
58.
Ferrari S, Rizzoli R, Manen D, Slosman D, Bonjour JP: Vitamin D receptor gene start codon polymorphisms (FokI) and bone mineral density: Interaction with age, dietary calcium, and 3′-end region polymorphisms. J Bone Miner Res 1998;13:925–930.
59.
Minamitani K, Takahashi Y, Minagawa M, Yasuda T, Niimi H: Difference in height associated with a translation start site polymorphism in the vitamin D receptor gene. Pediatr Res 1998;44:628–632.
60.
White CP, Morrison NA, Gardiner EM, Eisman JA: Vitamin D receptor alleles and bone physiology. J Cell Biochem 1994;56:307–314.
61.
Krall EA, Parry P, Lichter JB, Dawson-Hughes B: Vitamin D receptor alleles and rates of bone loss: Influences of years since menopause and calcium intake. J Bone Miner Res 1995;10:978–984.
62.
Fleet JC, Harris SS, Wood RJ, Dawson-Hughes B: The BsmI vitamin D receptor restriction fragment length polymorphism (BB) predicts low bone density in premenopausal black and white women. J Bone Miner Res 1995;10:985–990.
63.
Riggs BL, Nguyen TV, Melton IJ, Morrison NA, O’Fallon WM, Kelly PJ, Egan KS, Sambrook PN, Muhs JM, Eisman JA: The contribution of vitamin D receptor gene alleles to the determination of bone mineral density in normal and osteoporotic women. J Bone Miner Res 1995;10:991–996.
64.
Eisman JA: Vitamin D receptor gene alleles and osteoporosis: An affirmative view. J Bone Miner Res 1995;10:1289–1293.
65.
Beavan S, Prentice A, Yan L, Dibba B, Ralston S: Differences in vitamin D receptor genotype and geographical variation in osteoporosis. Lancet 1996;348:136–137.
66.
Young RP, Lau EMC, Birjandi Z, Critchley JAJ II, Woo J: Interethnic differences in hip fracture rate and the vitamin D receptor polymorphism. Lancet 1996;348:688–689.
67.
Uitterlinden AG, Pols HAP, Burger H, Huang Q, van Daele PLA, van Diujn CM, Hofman A, Birkenhäger JC, van Leeuwen JPTM: A large-scale population based study of the association of vitamin D receptor polymorphisms with bone mineral density. J Bone Miner Res 1996;11:1241–1248.
68.
Houston LA, Grant SFA, Reid DM, Ralston SH: Vitamin D receptor polymorphism, bone mineral density, and osteoporotic vertebral fracture: Studies in a UK population. Bone 1996;18:249–252.
69.
Need AG, Horowitz M, Stiliano A, Scopacasa F, Morris HA, Chatterton BE: Vitamin D receptor genotypes are related to bone size and bone density in men. Eur J Clin Invest 1996;26:793–796.
70.
Vandervyver C, Wylin T, Cassiman JJ, Raus J, Geusens P: Influence of the vitamin D receptor gene alleles on bone mineral density in postmenopausal and osteoporotic women. J Bone Miner Res 1997;12:241–247.
71.
Tamai M, Yokouchi M, Komiya K, Hidaka S, Narita S, Inoue A, Itoh K: Correlation between vitamin D receptor genotypes and bone mineral density in Japanese patients with osteoporosis. Calcif Tissue Int 1997;60:229–232.
72.
Lazaretti-Castro M, Duarte-de-Oliveira MA, Russo EMK, Vieira JHG: Vitamin D receptor alleles and bone mineral density in a normal premenopausal Brazilian female population. Braz J Med Biol Res 1997;30:929–932.
73.
Sigurdsson G, Magnusdottir DN, Kristinsson JÖ, Kristjansson K: Association of BsmI vitamin-D receptor gene polymorphism with combined bone mass in spine and proximal femur in Icelandic women. J Intern Med 1997;241:501–505.
74.
Ferrari SL, Rizzoli R, Slosman DO, Bonjour JP: Do dietary calcium and age explain the controversy surrounding the relationship between bone mineral density and vitamin D receptor gene polymorpisms? J Bone Miner Res 1998;13:363–370.
75.
Gennari L, Becherini L, Masi L, Mansani R, Gonnelli S, Cepollaro C, Martini S, Montagnani A, Lentini G, Becorpi AM, Brandi ML: Vitamin D and estrogen receptor allelic variants in Italian postmenopausal women: Evidence of multiple gene contribution to bone mineral density. J Clin Endocrinol Metab 1998;83:939–944.
76.
Gough A, Sambrook P, Devlin J, Lilley J, Huisoon A, Betteridge J, Franklyn J, Nguyen T, Morrison N, Eisman J, Emery P: Effect of vitamin D receptor gene alleles on bone loss in early rheumatoid arthritis. J Rheumatol 1998;25:864–868.
77.
Freskanich D, Hunter DJ, Willett WC, Hankonson SE, Hollis BW, Hough HL, Kelsey KT, Coldtiz GA: Vitamin D receptor genotype and the risk of bone fractures in women. Epidemiology 1998;9:535–539.
78.
Looney JE, Yoon HK, Fischer M, Farley SM, Farley JR, Werdegal JE, Baylink DJ: Lack of high prevalence of the BB vitamin D receptor genotype in severely osteoporotic women. J Clin Endocrinol Metab 1995;80:2158–2162.
79.
Peacock M: Vitamin D receptor gene alleles and osteoporosis: A contrasting view. J Bone Miner Res 1995;10:1294–1297.
80.
Garnero P, Borel O, Sornay-Rendu E, Arlot ME, Delmas PD: Vitamin D receptor gene polymorphisms are not related to bone turnover, rate of bone loss, and bone mass in postmenopausal women: The OFELY study. J Bone Miner Res 1996;11:827–834.
81.
Berg JP, Falch JA, Haug E: Fracture rate, pre- and postmenopausal bone mass and early and late postmenopausal bone loss are not associated with vitamin D recepptor genotype in a high-endemic area of osteoporosis. Eur J Endocrinol 1996;135:96–100.
82.
Ewald B, Eun-Kyun S, Richard MW, Thomas L, Dieter SWM, Simon P: Genotypes of the vitamin-D-receptor gene and bone mineral density in Caucasoid postmenopausal females. Maturitas 1996;24:91–96.
83.
Jorgensen HL, Scholler J, Sand JC, Bjuring M, Hassager C, Christiansen C: Relation of common allelic variation at vitamin D receptor locus to bone mineral density and postmenopausal bone loss: Cross-sectional and longitudinal study. BMJ 1996;313:586–590.
84.
Spotila LD, Caminis J, Johnston R, Shimoya KS, O’Connor MP, Prockop DJ, Tenenhouse A, Tenenhouse HS: Vitamin D receptor genotype is not associated with bone mineral density in three ethnic/regional groups. Calcif Tissue Int 1996;59:235–237.
85.
Alahari KD, Lobaugh B, Econs MJ: Vitamin D receptor alleles do not correlate with bone mineral density in premenopausal Caucasian women from the southeastern United States. Metabolism 1997;46:224–226.
86.
Francis RM, Harrington F, Turner E, Papiha SS, Datta HK: Vitamin D receptor gene polymorphism in men and its effect on bone density and calcium absorption. Clin Endocrinol 1997;46:83–86.
87.
Mocharla H, Butch AW, Pappas AA, Flick JT, Weinstein RS, De Togni P, Jilka RL, Robertson PK, Parfitt AM, Manolagas SC: Quantification of vitamin D receptor mRNA by competitive polymerase chain reaction in PBMC: Lack of correspondence with common allelic variants. J Bone Miner Res 1997;12:726–733.
88.
Zmuda JM, Cauley JA, Danielson ME, Wolf RL, Ferrell RE: Vitamin D receptor gene polymorphisms, bone turnover, and rates of bone loss in older African-American women. J Bone Miner Res 1997;12:1446–1452.
89.
Rauch F, Radermacher A, Danz A, Schiedermaier U, Golücke A, Michalk D, Schönau E: Vitamin D receptor genotypes and changes of bone density in physically active German women with high calcium intake. Exp Cin Endocrinol Diabetes 1997;105:103–108.
90.
Hansen TS, Abrahamsen B, Henriksen FL, Hermann AP, Jensen LB, Horder M, Gram J: Vitamin D receptor alleles do not predict bone mineral density of bone loss in Danish perimenopausal women. Bone 1998;22:571–575.
91.
Laskey MA, Prentice A, Hanratty LA, Jarjou LMA, Dibba B, Beavan SR, Cole TJ: Bone changes after 3 months of lactation: Influence of calcium intake, breast-milk output, and vitamin D-receptor genotype. Am J Clin Nutr 1998;67:685–692.
92.
Sosa Henríquez M, Torres Ramírez A, Domínguez Cabrera C, Salido E, Saavedra Santana P, Barrios Y, Limiñana Cañal J, Betancor León P: Polimorfismo genético del receptor de la vitamina D y osteoporosis. Medic Clin (Barc) 1998;110:646–650.
93.
Ramalho AC, Lazaretti-Castro M, Hauache O, Kasamtsu T, Brandao C, Reis AF, Takata E, Cafalli F, Tavares F, Gimeno SGA, Vieira JGH: Fractures of the proximal femur: Correlation with vitamin D receptor gene polymorphism. Braz J Med Biol Res 1998;31:921–927.
94.
Järvinen TLN, Järvinen TAH, Sievänen H, Heinonen A, Tanner M, Huang XH, Nenonen A, Isola JJ, Järvinen M, Kannus P: Vitamin D receptor alleles and bone’s response to physical activity. Calcif Tissue Int 1998;62:413–417.
95.
Kung AWC, Yeung SSC, Lau KS: Vitamin D receptor gene polymorphisms and peak bone mass in Southern Chinese women. Bone 1998;22:389–393.
96.
Econs MJ, Speer MC: Genetic studies of complex diseases: Let the reader beware. J Bone Miner Res 1996;12:1835–1840.
97.
Cooper GS, Umbach DM: Are vitamin D receptor polymorphisms associated with bone mineral density? A meta-analysis. J Bone Miner Res 1996;12:1841–1849.
98.
Seeman E, Hopper JL, Young NR, Formica C, Goss P, Tsalamandris C: Do genetic factors explain associations between muscle strength, lean mass, and bone density? A twin study. Am J Physiol 1996;270:E320–E327.
99.
Matkovic V: Nutrition, genetics and skeletal development. J Am Coll Nutr 1996;15:556–569.
100.
Nelson DA, Kleerekoper M: Editorial: The search for the osteoporosis gene. J Clin Endocrinol Metab 1997;82:989–990.
101.
Rauch F, Radermacher A, Schönau E: Prediction of bone density from vitamin D receptor alleles; in Schönau E (ed): Paediatric Osteology: New Developments in Diagnostics and Therapy. Amsterdam, Elsevier Science, 1996, pp 59–65.
102.
Morrison N: Vitamin D receptor gene variants and osteoporosis: A contributor to the polygenic control of bone density; in Feldman, Glorieux, Pike (eds): Vitamin D. New York, Academic Press, 1997, pp 713–731.
103.
Kelly PJ, Hopper JL, Macaskill GT, Pocock NA, Sambrook PN, Eisman JA: Genetic factors in bone turnover. J Clin Endocrinol Metab 1991;72:808–813.
104.
Tokita A, Kelly PJ, Nguyen TV, Qi JC, Morrison NA, Risteli L, Risteli J, Sambrook PN, Eisman JA: Genetic influences on type I collagen synthesis and degradation: Further evidence for genetic regulation of bone turnover. J Clin Endocrinol Metab 1994;78:1461–1466.
105.
Howard G, Nguyen T, Morrison N, Watanabe T, Sambrook P, Eisman J, Kelly P: Genetic influences on bone density: Physiological correlates of vitamin D receptor gene alleles in premenopausal women. Notification of genotype corrections. J Clin Endocrinol Metab 1998;83:1043.
106.
Matkovic V, Ilich JZ, Klisovic D, Skugor M, Badenhop N, An B, Vereault D, Rosen CJ, Young AP: Vitamin-D-receptor gene (VDR) polymorphism differentiated insulin-like growth factor (IGF-I) and body composition during growth. B Bone Miner Res 1996;11:S209.
107.
Harrela M, Koistinen H, Kaprio J, Lehtovirta M, Tuomilehto J, Eriksson J, Toivanan L, Koskenvuo M, Leinonen P, Koistinen R, Seppälä M: Genetic and environmental components of interindividual variation in circulating levels of IGF-I, IGF-II, IGFBP-1 and IGFBP-3. J Clin Invest 1996;98:2612–2615.
108.
Wishart JM, Horowitz M, Need AG, Scopacasa F, Morris HA, Clifton PM, Nordin BEC: Relations between calcium intake, calcitriol, polymorphisms of the vitamin D receptor gene, and calcium absorption in premenopausal women. Am J Clin Nutr 1997;65:798–802.
109.
Gross C, Musio IM, Eccleshall TR, Malloy OJ, Feldman D: Vitamin D receptor gene polymorphisms: Analysis of ligand binding and hormone responsiveness in cultured fibroblasts. Biochem Biophys Res Commun 1998;242:467–473.
110.
Gross C, Krishnan AV, Malloy PJ, Eccleshall TR, Zhao XY, Feldman D: The vitamin D receptor gene start codon polymorphism: A functional analysis of Fok I variants. J Bone Miner Res 1998;13:1691–1699.
111.
Howard G, Kelly P, Morrison N, Tokita A, Watanabe T, Sambrook P, Nguyen T, Eisman J: Functional significance of vitamin D receptor alleles: Response of bone turnover indices to calcitriol stimulation. J Bone Miner Res 1994;9:S134.
112.
Matsuyama T, Ishii S, Tokita A, Yabuta K, Yamamori S, Morrison NA, Eisman JA: Vitamin D receptor genotypes and bone mineral density. Lancet 1995;345:1238–1239.
113.
Graafmans WC, Lips P, Ooms ME, van Leeuwen JPM, Pols HAP, Uitterlinden AG: The effect of vitamin D supplementation on the bone mineral density of the femoral neck is associated with vitamin D receptor genotype. J Bone Miner Res 1997;12:1241–1245.
114.
Ferrari S, Rizzoli R, Bonjour JP: Heritable and nutritional influences on bone mineral mass. Aging Clin Exp Res 1998;10:205–213.
115.
Specker BL, Williams LA, Kalkwarf H, Langland C, Ho M, Hess H, Gidens J, Wenstrup RJ: Vitamin D receptor genotype and its relation to bone growth and bone mineralization in infants 3 to 12 months of age. J Bone Miner Res 1995;10(suppl 1):185.
116.
Klisovic D, Young AP, Ilich JZ, Skugor M, Badenhop N, Matkovic V: Vitamin D receptor gene polymorphism (VDR) and bone mineral density (BMD) in prepubertal females. J Bone Miner Res 1995;10(suppl 1):189.
117.
Ferrari SL, Rizzoli R, Theintz G, Slosman DO, Bonjour JP: Vitamin D-receptor (VDR) gene polymorphisms and the effects of calcium supplementation on bone mass accumulation in prepubertal girls. J Bone Miner Res 1995;10(suppl 1):187.
118.
Ferrari SL, Rizzoli R, Eisman JA, Theintz G, Slosman DO, Bonjour JP: Mother-daughter BMD similarities in relation to vitamin D receptor (VDR) gene alleles. Calcif Tissue Int 1995;56:474.
119.
Sainz J, Van Tornout JM, Loro ML, Sayre J, Roe TF, Gilsanz V: Vitamin D-receptor gene polymorphisms and bone density in prepubertal American girls of Mexican descent. N Engl J Med 1997;337:77–82.
120.
Tao C, Yu T, Garnett S, Briody J, Knight J, Woodhead H, Cowell CT: Vitamin D receptor alleles predict growth and bone density in girls. Arch Dis Child 1998;79:488–494.
121.
Suarez F, Rossignol C, Garabédian M: Interactive effect of estradiol and vitamin D receptor gene polymorphisms as a possible determinant of growth in male and female infants. J Clin Endocrinol Metab 1998;83:3563–3568.
122.
Keen RW, Egger P, Fall C, Major PJ, Lanchbury JS, Spector TD, Cooper C: Polymorphisms of the vitamin D receptor, infant growth, and adult bone mass. Calcif Tissue Int 1997;60:233–235.
123.
Carling T, Kindmark A, Hellman P, Holmberg L, Akerström G, Rastad J: Vitamin D receptor alleles b, a and T: Risk factors for sporadic hyperparathyroidism (HPT) but not HPT of uremia or MEN 1. Biochem Biophys Res Commun 1997;231:329–332.
124.
Carling T, Kindmark A, Hellman P, Lundgren E, Ljundhall S, Rastad J, Akerström G, Melhus H: Vitamin D receptor genotypes in primary hyperparathyroidism. Nat Med 1995;1:1309–1311.
125.
Carling T, Ridefelt P, Hellman P, Rastad J, Akerström G: Vitamin D receptor polymorphisms correlate to parathyroid cell function in primary hyperparathyroidism. J Clin Endocrinol Metab 1997;82:1772–1775.
126.
Carling T, Rastad J, Akerström G, Westin G: Vitamin D receptor (VDR) and parathyroid hormone messenger ribonucleic acid levels correspond to polymorphic VDR alleles in human parathyroid tumors. J Clin Endocrinol Metab 1998;83:2255–2259.
127.
Torres A, Machado M, Concepción MT, Martín N, Lorenzo V, Hernández D, Rodríguez AP, Rodríguez A, de Bonis E, González-Posada JM, Hernández A, Salido E: Influence of vitamin D receptor genotype on bone mass changes after renal transplantation. Kidney Int 1996;50:1726–1733.
128.
Fernández E, Fibla J, Betriu A, Piulats JM, Almirall J, Montoliu J: Association between vitamin D receptor gene polymorphism and relative hypoparathyroidism in patients with chronic renal failure. J Am Soc Nephrol 1997;8:1546–1552.
129.
Yokoyama K, Shigematsu T, Tsukada T, Ogura Y, Takemoto F, Hara S, Yamada A, Kawaguchi Y, Hosoya T: Apa I polymorphism in the vitamin D receptor gene may affect the parathyroid response in Japanese with end-stage renal disease. Kidney Int 1998;53:454–458.
130.
Feldman D: Androgen and vitamin D receptor gene polymorphisms: The long and short of prostate cancer risk. J Natl Cancer Inst 1997;89:109–111.
131.
Taylor JA, Hirvonen A, Watson M, Pittman G, Mohler JL, Bell DA: Association of prostate cancer with vitamin D receptor gene polymorphism. Cancer Res 1996;56:4108–4110.
132.
Ingles SA, Ross RW, Yu MC, Irvine RA, La Pera G, Haile RW, Coetzee GA: Association of prostate cancer risk with vitamin D receptor and androgen receptor genetic polymorphisms. J Natl Cancer Inst 1997;89:166–170.
133.
Ingles S, Haile R, Henderson B, Kolonel L, Coetzee G: Association of vitamin D receptor genetic polymorphism with breast cancer risk in African-American and Hispanic women; in Norman A, Bouillon R, Thomasset M (eds): Vitamin D: Chemistry, Biology and Clinical Applications of the Steroid Hormone. Riverside, University of California, Printing and Reprographics, 1997, pp 813–814.
134.
Ingles SA, Coetzee GA, Ross RK, Henderson BE, Kolonel LN, Corcitto L, Wang W, Haile RW: Association of prostate cancer with vitamin D receptor haplotypes in African-Americans. Cancer Res 1998;58:1620–1623.
135.
Ma J, Stampfer MJ, Gann PH, Hough HL, Giovannucci E, Kelsey KT, Hennekens CH, Hunter DJ: Vitamin D receptor polymorphisms, circulating vitamin D metabolites, and risk of prostate cancer in United States physicians. Cancer Epidemiol Biomarkers Prev 1998;7:385–390.
136.
Ruggiero M, Pacini S, Aterini S, Fallai C, Ruggiero C, Pacini P: Vitamin D receptor gene polymorphism is associated with metastatic breast cancer. Oncol Res 1998;10:43–46.
137.
Mundy GR: The genetics of osteoporosis. Endocrinologist 1995;5:176–179.
138.
Ferrari S, Bonjour JP, Rizzoli R: The vitamin D receptor gene and calcium metabolism. TEM 1998;9:259–265.
139.
Turner RT, Rigs BL, Spelsberg TC: Skeletal effects of estrogen. Endocr Rev 1994;15:275–300.
140.
Korach KS: Insights from the study of animals lacking functional estrogen receptor. Science 1994;266:1524–1527.
141.
Smith EP, Boyd J, Frank GR, Takahashi H, Cohen RM, Specker B, Williams TC, Lubahn DB, Korach KS: Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man. N Engl J Med 1994;331:1056–1061.
142.
Morishima A: Aromatase deficiency in the male: The physiologic role of estrogens. Clin Endocrinol J 1996;44:65–74.
143.
MacGillivray MH, Morishima A, Conte F, Grumbach M, Smith EP: Pediatric endocrinology update: An overview. The essential roles of estrogens in pubertal growth, epiphyseal fusion and bone turnover: Lessons from mutations in the genes for aromatase and the estrogen receptor. Horm Res 1998;49 (suppl 1):2–8.
144.
Bilezikian JP, Morishima A, Bell J, Grumbach MM: Brief report: Increased bone mass as a result of estrogen therapy in a man with aromatase deficiency. N Engl J Med 1998;339:599–603.
145.
Han KO, Moon IG, Kang YS, Chung HY, Min HK, Han IK: Nonassociation of estrogen receptor genotypes with bone mineral density and estrogen responsiveness to hormone replacement therapy in Korean postmenopausal women. J Clin Endocrinol Metab 1997;82:991–995.
146.
Jorgensen HL, Heegaard AM, Bayer L, Hansen L, Hassger C: PvuII and Xbal restriction fragment length polymorphisms at the estrogen receptor (ER) locus and its relation to bone mineral density (BMD) and bone loss in postmenopausal Danish women. J Bone Miner Res 1997;12(suppl 1):T612.
147.
Hoshino S, Inoue S, Hosoi T, Saito T, Ikegami A, Kaneki M, Ouchi Y, Orimo H: Demonstration of isoforms of the estrogen receptor in the bone tissues and in osteoblastic cells. Calcif Tissue Int 1995;57:466–468.
148.
Sano M, Inoue S, Hosoi T, Ouchi Y, Emi M, Shiraki M, Orimo H: Association of estrogen receptor dinucleotide repeat polymorphism with osteoporosis. Biochem Biophys Res Commun 1995;217:378–383.
149.
Van Leuwen JPTM, Uitterlinden AG, Burger H, Huang Q, Birkenhäger JC, Pols HAP: Estrogen receptor genotypes and bone mineral density: The Rotterdam study; in Papapoulos SE, Lips P, Johnston CC, Delmas PD (eds): Osteoporosis 1996. Amsterdam, Elsevier Science, 1996, pp 171–173.
150.
Kobayashi S, Inoue S, Hosoi T, Ouchi Y, Shiraki M, Orimo H: Association of bone mineral density with polymorphisms of the estrogen receptor gene. J Bone Miner Res 1996;11:306–311.
151.
Mahonen A, Turunen AM, Kroger H, Maenpaa PH: Estrogen receptor gene polymorphism is associated with bone mineral density in perimenopausal Finnish women. J Bone Miner Res 1997;12(suppl 1):T614.
152.
Langdahl BL, Lokke E, Carstens M, Eriksen EF: Polymorphisms in the estrogen receptor gene show different distributions in osteoporotic patients and normal controls. J Bone Miner Res 1997;12:(suppl 1):255.
153.
Willing M, Sowers M, Aron D, Clark MK, Burns T, Bunten C, Crutchfield M, D’Agostino D, Jannausch M: Bone mineral density and its change in white women: Estrogen and vitamin D receptor genotypes and their interaction. J Bone Miner Res 1998;13:695–705.
154.
Ushiyama T, Ueyama H, Inoue K, Nishioka J, Ohkubo I, Hukuda S: Estrogen receptor gene polymorphism and generalized osteoarthritis. J Rheumatol 1998;25:134–137.
155.
Harada N, Utsumi T, Takagi Y: Tissue-specific expression of the human aromatase cytochrome P450 gene by alternative use of multiple exons I and promoters, and switching of tissue-specific exons I in carcinogenesis. Proc Natl Acad Sci USA 1993;90:11312–11316.
156.
Nawata H, Tanaka S, Takayanagi R, Sakai Y, Yanase T, Ikuyama S, Haji M: Aromatase in bone cell: Association with osteoporosis in postmenopausal women. J Steroid Biochem Mol Biol 1995;53:165–174.
157.
Spotila LD, Constantinou CD, Sereda L, Ganguly A, Riggs BL, Prockop DJ: Mutation in a gene for type I procollagen (COL1A2), in a women with postmenopausal osteoporosis: Evidence for phenotypic and genotypic overlap with mild osteogenesis imperfecta. Proc Natl Acad Sci USA 1991;88:5423–5427.
158.
Spotila LD, Colige A, Sereda L, Constantinos-Deltas CD, Whyte MP, Riggs BL, Shaker JL, Spector TD, Hume E, Olsen N, Attie M, Tenenhouse A, Shane E, Briney W, Prockop DJ: Mutation analysis of coding sequences for type I procollagen in individuals with low bone density. J Bone Miner Res 1994;9:923–932.
159.
Shapiro JR, Stover ML, Burn VE, McKinstry MB, Burshell AL, Chipman SD, Rowe DW: An osteopenic nonfracture syndrome with features of mild osteogenesis imperfecta associated with the substitution of a cysteine for glycine at triple helix position 43 in the proα1(I) chain of type I collagen. J Clin Invest 1992;89:567–573.
160.
Byers PH: Osteogenesis imperfecta; in Royce PM, Steinmann B (eds): Connective Tissues and Its Heritable Disorders. New York, Wiley-Liss, 1993, pp 317–350.
161.
Spotila LD, Caminis J, Devoto M, Shimoya K, Sereda L, Ott J, Whyte MP, Tenenhouse A, Prockop DJ: Osteopenia in 37 members of seven families: Analysis based on a model of dominant inheritance. Mol Med 1996;2:313–324.
162.
Grant SFA, Reid DM, Blake G, Herd R, Fogelman I, Ralston SH: Reduced bone density and osteoporosis associated with a polymorphic Sp1 binding site in the collagen type I α1 gene. Nat Genet 1996;14:203–205.
163.
Langdahl BL, Ralston SH, Grant SFA, Eriksen EF: An Sp1 binding site polymorphism in the COLIA1 gene predicts osteoporotic fractures in both men and women. J Bone Miner Res 1998;13:1384–1389.
164.
Roux C, Dougados M, Abel L, Mercier G, Lucotte G: Association of a polymorphism in the collagen I α1 gene with osteoporosis in French women. Arthritis Rheum 1998;41: 187–188.
165.
Uitterlinden AG, Burger H, Huang WJ, Yue F, McGuigan FEA, Grant SFA, Hofman A, Vanleeuwen JPTM, Pols HAP, Ralston SH: Relation of alleles of the collagen type I α1 gene to bone density and risk of osteoporotic fractures in postmenopausal women. N Engl J Med 1998;338:1016–1021.
166.
Beavan S, Prentice A, Dibba B, Yan L, Cooper C, Ralston SH: Polymorphism of the collagen type I α1 gene and ethnic differences in hip-fracture rates. N Engl J Med 1998;339:351–352.
167.
Garnero P, Borel O, Grant SFA, Ralston SH, Delmas PD: Collagen Iα1 Sp1 polymorphism, bone mass, and bone turnover in healthy French premenopausal women: The OFELY study. J Bone Miner Res 1998;13:813–817.
168.
Hampson G, Evans C, Petitt RJ, Evans WD, Woodhead SJ, Peters JR, Ralston SH: Bone mineral density, collagen type 1α1 genotypes and bone turnover in premenopausal women with diabetes mellitus. Diabetologia 1998;41:1314–1320.
169.
Liska DAJ, Robinson VR, Bornstein P: Elements in the first intron of the alpha-1-(I)-collagen gene interact with Sp1 to regulate gene expression. Gene Expr 1992;2:379–389.
170.
Bonewald LF, Mundy GR: Role of transforming growth factor-beta in bone remodeling. Clin Orthop 1990;250:261–276.
171.
Mundy GR, Bonewald LF: Transforming growth factor-beta; in Gowen M (ed): Cytokines and Bone Metabolism. Boca Raton, CRC Press, 1992, pp 93–107.
172.
Langdahl BL, Knudsen JY, Jensen HK, Gregersen N, Eriksen EF: A sequence variation: 713-8delC in the transforming growth factor-beta-1 gene has higher prevalence in osteoporotic women than in normal women and is associated with very low bone mass in osteoporotic women and increased bone turnover in both osteoporotic and normal women. Bone 1997;20:289–294.
173.
Yamada Y, Miyauchi A, Goto J, Takagi Y, Okuizumi H, Kanematsu M, Hase M, Takai H, Harada A, Ikeda K: Association of a polymorphism of the transforming growth factor-β1 gene with genetic susceptibility to osteoporosis in postmenopausal Japanese women. J Bone Miner Res 1998;13:1569–1576.
174.
Bowcock AM, Ray A, Erlich H, Sehgal PB: Rapid detection and sequencing of alleles in the 3′ flanking region of the interleukin-6 gene. Nucl Acid Res 1989;17:6855–6864.
175.
Murray RE, Grant SFA, Reid DM, Ralston SH: Bone mineral density and polymorphisms of the interleukin-6 gene; in Papapoulos SE, Lips P, Johnston CC, Delmas PD (eds): Osteoporosis 1996. Amsterdam, Elsevier Science, 1996, pp 167–170.
176.
Murray RE, McGuigan F, Grant SFA, Reid DM, Ralston SH: Polymorphisms of the interleukin-6 gene are associated with bone mineral density. Bone 1997;21:89–92.
177.
Moore EE, Kuestner RE, Stropp SD, Grant FJ, Matthewes SL, Brady CL, Sexton PM, Findlay DM: Functionally different isoforms of the human calcitonin receptor result from alternative splicing of the gene transcript. Mol Endocrinol 1995;9:959–968.
178.
Gorn AH, Rudolph SM, Flannery MR, Morton CC, Weremowicz S, Wang JT, Krane SM, Goldring SR: Expression of two human skeletal calcitonin receptor isoforms cloned from a giant cell tumor of bone. J Clin Invest 1995;95:2580–2691.
179.
Nakamura M, Zhang ZQ, Shan L, Hisa T, Sasaki M, Tsukino R, Yokoi T, Kaname A, Kakudo K: Allelic variants of human calcitonin receptor in the Japanese population. Hum Genet 1997;99:38–41.
180.
Masi L, Becherini L, Gennari L, Colli E, Mansani R, Falchetti A, Cepollaro C, Gonnelli S, Tanini A, Brandi ML: Allelic variants of human calcitonin receptor: Distribution and association with bone mass in postmenopausal women. Biochem Biophys Res Commun 1998;245:622–626.
181.
Masi L, Becherini L, Colli E, Gennari L, Mansani R, Falchetti A, Becorpi AM, Cepollaro C, Gonnelli S, Tanini A, Brandi ML: Polymorphisms of the calcitonin receptor gene are associated with bone mineral density in postmenopausal Italian women. Biochem Biophys Res Commun 1998;248:190–195.
182.
Conn KM, Termine JD: Matrix protein profiles in calf development. Bone 1985;6:33–36.
183.
Osawa M, Umetsu K, Ohki T, Nahasawa T, Suzuki T, Takeichi S: Molecular evidence for human alpha-2-HS glycoprotein (AHSG) polymorphism. Hum Genet 1997;99:18–21.
184.
Eichner JE, Cauley JA, Ferrell RE, Cummings SR, Kuller LH: Genetic variation in two bone-related proteins: Is there an association with bone mineral density or skeletal size in postmenopausal women? Genet Epidemiol 1992;9:177–184.
185.
Dickson IR, Gwilliam R, Arora M: Lumbar vertebral and femoral neck bone mineral density are higher in postmenopausal women with the alpha-2HS-glycoprotein 2 phenotype. Bone Miner 1994;24:181–188.
186.
Zmuda JM, Eichner JE, Ferrell RE, Bauer DC, Kuller LH, Cauley JA: Genetic variation in α2HS-glycoprotein is related to calcaneal broadband ultrasound attenuation in older women. Calcif Tissue Int 1998;63:5–8.
187.
Dohi Y, Iki M, Ohgushi H, Gojo S, Tabata S, Kajita E, Nishino H, Yonemasu K: A novel polymorphism in the promoter region for the human osteocalcin gene: The possibility of a correlation with bone mineral density in postmenopausal Japanese women. J Bone Miner Res 1998;13:1633–1639.
188.
Cole DEC, Peltekova VD, Rubin LA, Hawker GA, Vieth R, Liew CC, Hwang D, Evrosvski J, Hendy GN: Genetic determinants of serum calcium: Potential roles for the A986S and R990G polymorphisms of the calcium-sensing receptor (CASR) gene. J Bone Miner Res 1997;12(suppl 1):257.
189.
Keen RW, Woodford-Richens KL, Major PJ, Lanchbury JS, Spector TD: Early menopausal bone loss at the spine is associated with polymorphism at the interleukin-1 receptor antagonist locus. J Bone Miner Res 1997;12 (suppl 1):256.
190.
Keen RW, Woodford-Richens KL, Lanchbury JS, Spector TD: Allelic variation at the interleukin-1 receptor antagonist gene is associated with early postmenopausal bone loss at the spine. Bone 1998;23:367–371.
191.
Han KO, Moon IG, Coi JT, Chung HY, Yoon HK, Min HK, Han IK: Association study of bone density and bone turnover with polymorphism of interleukin-1 receptor antagonist gene in Korean postmenopausal women. J Bone Miner Res 1997;12(suppl 1):256.
192.
Matkovic V, Skugor M, Ilich JH, Klisovic D, Badenhop NE, Nagode LA, Landoll L: Serum leptin and β3-adrenergic-receptor gene (β-ARG) polymorphism in osteoarthritic (OA) and osteoporotic (OP) patients. J Bone Miner Res 1997;12(suppl 1):257.
193.
Fujisawa T, Ikegami H, Kawaguchi Y, Ogihara T: Meta-analysis of the association of Trp64Arg polymorphism of β3-adrenergic receptor gene with body mass index. J Clin Endocrinol Metab 1998;83:2441–2444.
194.
Shiraki M, Shiraki Y, Aoki C, Hosoi T, Inoue S, Kaneki M, Ouchi Y: Association of bone mineral density with apolipoprotein E phenotype. J Bone Miner Res 1997;12:1438–1445.
195.
Hosoi T, Miyao M, Inoue S, Shiraki M, Orimo H, Ouchi Y: Candidate-gene approach for the genetic basis of postmenopausal osteoporosis. J Bone Miner Res 1997;12(suppl 1):494.
196.
Rosen CJ, Kurkland ES, Vereault D, Adler RA, Rackoff PJ, Craig WY, Witte S, Rogers J, Bilezikian JP: Association between serum insulin growth factor-I (IGF-I) and a simple sequence repeat in IGF-I gene: Implications for genetic studies of bone mineral density. J Clin Endocrinol Metab 1998;83:2286–2290.
197.
Meulenbelt I, Bijkerk C, Miedema HS, Breedveld FC, Hofman A, Valkenburg HA, Pols HAP, Slagboom PE, van Duijn CM: A genetic association study of the IGF-I gene and radiological osteoarthritis in a population-based cohort study (the Rotterdam study). Ann Rheum Dis 1998;57:371–374.
198.
Tsuji S, Munkhbat B, Hagihara M,Tsuritani I, Abe H, Tsuji K: HLA-B*07 and DRB*01 haplotype as a genetic marker for peak bone mass in Japanese women. J Bone Miner Res 1997;12(suppl 1):494.
199.
Tsuji S, Munkhbat B, Hagihara M, Tsuritani I, Abe H, Tsuji K: HLA-A-A*24-B*07-DRB1*01 haplotype implicated with genetic disposition of peak bone mass in healthy young Japanese women. Hum Immunol 1998;59:243–249.
200.
Huizenga NATM, Koper JW, De Lange P, Pols HAP, Stolk RP, Burger H, Grobbee DE, Brinkmann AO, De Jong FH, Lamberts SWJ: A polymorphism in the glucocorticoid receptor gene may be associated with an increased sensitivity to glucocorticoids in vivo. J Clin Endocrinol Metab 1998;83:144–151.
201.
Gong Y, Vikkula M, Boon L, Liu J, Beighton P, Ramesar R, Peltonen L, Somer H, Hirose T, Dallapiccola B, De Paepe A, Swoboda W, Zabel B, Superti-Furga A, Steinmann B, Brunner HG, Jans A, Boles RG, Adkins W, van den Boogaard MJ, Olsen BR, Warman ML: Osteoporosis-pseudoglioma syndrome, a disorder affecting skeletal strength and vision, is assigned to chromosome region 11q12-13. Am J Hum Genet 1996;59:146–151.
202.
Johnson ML, Gong G, Kimberling W, Recker SM, Kimmel DB, Recker RR: Linkage of a gene causing high bone mass to human chromosome 11 (11q12-13). Am J Hum Genet 1997;60:1326–1332.
203.
Devoto M, Shimoya K, Caminis J, Ott J, Tenenhouse A, Whyte MP, Sereda L, Hall S, Considine E, Williams CJ, Tromp G, Kuivaniemi H, Ala-Kokko L, Prockop DJ, Spotila LD: First-stage autosomal genome screen in extended pedigrees suggests genes predisposing to low bone mineral density on chromosomes 1p, 2p and 4q. Eur J Hum Genet 1998;6:151–157.
1999
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.